Chronic Kidney Disease (CKD) Dr. Sham Sunder. Now we know why the titanic sank !! < 0.5 % 5- 10%

Slides:



Advertisements
Similar presentations
Chronic Kidney Disease Manju Sood GPST3. What is CKD? Chronic renal failure is the progressive loss of nephrons resulting in permanent compromise of renal.
Advertisements

Lysaght, J Am Soc Nephrol, 2002 Number of patients worldwide treated with chronic dialysis from 1990 to ,000 1,490,000 2,500,000.
Chronic kidney disease: [insert title here] Insert name, title, date here Insert acknowledgements here.
Recent Advances in Management of CRF Yousef Boobess, M.D. Head, Nephrology Division Tawam Hospital.
Renal replacement therapy - indications. S. Zmonarski.
Renal Replacement Therapy: What the PCP Needs to Know.
SLOW- COOKING THE BEANS “OR, HOW TO STOP WORRYING AND APPLY SOME LOVE TO THE KIDNEYS” AN APPROACH TO CKD SARA KATE LEVIN, MD JANUARY 2014.
General Practice Workshop This workshop was conceived and developed by Kidney Health Australia’s Kidney Check Australia Taskforce with particular thanks.
Calcium & phosphor disturbance CKD- MBD Dr. Atapour.
FFBI Change Concepts FFBI Change Concept #12 Presented by: Ellen DePrat, MSN, RN, NE, CPHQ Project Coordinator - HealthInsight (QIO for Nevada/Utah) October.
CKD In Primary Care Dr Mohammed Javid.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Lesley Stevens MD Tufts-New England Medical Center
Feast or Famine: Survival and Chronic Kidney Disease Kerin Worley and Deb Gipson UNC Chapel Hill April, 2004.
Prevalance of Chronic Kidney Disease 26 million people have diagnosed chronic kidney 26 million people have diagnosed chronic kidney disease (CKD) ( National.
BY: DR. NAUSHAD PERVEZ.  Chronic Kidney Disease (CKD)
Section 1: CKD Epidemiology. The Problem Chronic Kidney Disease is an epidemic worldwide –Growth 6-8% per annum of dialysis patients Accumulating data.
Early Detection and Prevention of Renal Failure Linda Fried, MD, MPH.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
A significant proportion of diabetic patients develop diabetic nephropathy which can eventually progress to end-stage renal disease despite established.
Section 4: Managing progression of CKD. Glomerulosclerosis Reduction in number of functioning glomeruli Increased blood flow to remaining nephrons Intraglomerular.
RENAL DISEASE IN DIABETES
CHRONIC RENAL FAILURE JAKUB ZÁVADA KLINIKA NEFROLOGIE 1.LF UK.
Dr Rajendra Prasad Mathur MD, DM, FICP, ISN Scholar Seniour consultant & HOD, Batra hospital Heart and Kidney: Protect Your Kidneys to Save Your Heart.
Diabetes and Kidney. Diabetic Kidney Normal Kidney.
SM Gatmiri, MD, Nephrologist Imam Khomeini Hospital,
The National Kidney Foundation’s Kidney Early Evaluation Program TM “The Greater New York Experience” Ellen H. Yoshiuchi, MPS Division Program Director.
New Concepts in Chronic Kidney Disease Jonathan B. Jaffery, MD Assistant Professor of Medicine University of Wisconsin-Madison.
If I had Chronic Kidney Disease: What would I want my Doctor to Know….. Liam Plant Department of Renal Medicine, Cork University Hospital Department of.
Stage 4 CKD presentation in patients over 75 Years Old differs from that in patients less than 75 Years of Age Hiromichi Suzuki, Tsutomu Inoue,Tomohiro.
J Winterbottom 2005 Chronic Renal Failure Jean Winterbottom Clinical Educator MRI.
Section 5: Configuration of healthcare to manage CKD.
Dr M Sivalingam Renal Unit, Lister Hospital, Stevenage.
CKD Dr;BASHARDOOST. CKD –SOME DEFINITIONS IRREVERSIBLE LOSS OF GFR CKD results when a disease process damages the structural or functional integrity of.
2-4. Estimated Renal Function Estimated GFR = 1.8 x (Cs) x (age) Cockcroft-Gault eq. – Estimated creatine clearance (mL/min) = (140 – age x body weight,
Dietary Issues in Renal Complications Ulrich Wahl, Tamworth, 2010.
Chronic Kidney Disease: Treatment. Slowing the Progression of CKD Protein Restriction – KDOQI guidelines g/kg per day – Sufficient energy.
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
CHRONIC KIDNEY DISEASE
Progression of Chronic Kidney Disease
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
Diabetes And Hemodialysis 1 Dr.Ruba Nashawati. 2.
1 به نام خدا. Epidemiology of chronic kidney disease 2.
Gilead -Topics in Human Pathophysiology Fall 2009 Drug Safety and Public Health.
Professor Tazeen H Jafar Duke-National University of Singapore & Aga Khan University, Karachi, Pakistan Chronic Kidney Disease- Integration into the NCD.
Sheffield Kidney Institute Global Kidney Academy CKD Micro-Lecture Epidemiology, Screening and Guidelines Professor Meguid El Nahas, PhD, FRCP Sheffield.
Date of download: 6/23/2016 From: Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive.
Renal Disorders NUR 171 Professor Losicki R.N. MSN.
Section 1: CKD Epidemiology
National service framework for Renal
Section 4: Managing progression of CKD
The LIVES Sub-analysis
Darshika Chhabra, MD, MPH
Chapter 1: CKD in the General Population
Current and future management of diabetic renal failure
Acute and Chronic Renal Failure
Renal Disease Filtration, glomeruli generate removal ultrafiltrate of the plasma based on size and charge of molecules End products include urea, creatinine,
Dialysis Options: What is the Best Choice for You. Ana C
Diuretics, Kidney Diseases Urine R&M
Nat. Rev. Nephrol. doi: /nrneph
Need to Know! Screening and Diagnosis of Kidney Disease in Diabetes
Chapter 1: CKD in the General Population
به نام خدا.
Section 5: Configuration of healthcare to manage CKD
Recognizing Chronic Kidney Disease in Children
Volume 72, Issue 10, Pages (November 2007)
Meeting the challenges of the new K/DOQI guidelines
Volume 75, Issue 10, Pages (May 2009)
American Journal of Kidney Diseases
Lipids, the Heart, and the Kidney
Presentation transcript:

Chronic Kidney Disease (CKD) Dr. Sham Sunder

Now we know why the titanic sank !! < 0.5 % 5- 10%

CKD – A scary Challenge for Us all !! CKD – Chronic kidney disease

We have intricate things to learn !!

Practice Guidelines of CKD The National Kidney Foundation (NKF) National Kidney Diseases Education Program The NKDEP KIDNEY / DISEASE OUTCOMES QUALITY INITIATIVE The K/DOQI

Physicians Must be Engaged Indian scenario lak pts with eGFR ml/min/1.73 m 2 2. Pts with albuminuria are double this number 3. About 2,000 full-time nephrologists 4. Nearly 4,000 new patients per nephrologist 5. Means 11 new pts per day per nephrologist 6. Obviously not possible. Physicians must treat CKD

CKD – A Silent Killer CKD – Increased Death CKD at a glance CKD – A Global Pandemic CKD – A Global Pandemic CKD 1-2 are asymptomatic CKD 1-2 are asymptomatic Third after CVD, Cancer Third after CVD, Cancer 1 in 10 Indians have CKD 1 in 10 Indians have CKD 10 million people of CKD 10 million people of CKD Term ‘CRF’ no longer used Term ‘CRF’ no longer used Dialysis ↑ death rate 100 x Dialysis ↑ death rate 100 x Small ↑ in Creat - ↑ ↑ in CV Small ↑ in Creat - ↑ ↑ in CV

The Nephron

Filtration, Reabsorption and Secretion Normal GFR 120 ml/min/1.73m 2 Only 20% nephrons work at a time In a day 210 L of water is filtered 2 L /day of urine is excreted

Definition of CKD 1. Either GFR < 60 ml/min/1.73m 2 for  3 mon or 2. Kidney damage for  3 mon as manifested by a. Persistent microalbuminuria / macroproteinuria b. Biochemical abnormalities in RFT c. Persistent non-urological hematuria d. Structural renal abnormalities by USG e. Biopsy proven Glomerulonephritis (rarely needed) (Any one of the above evidences)

CKD Clinical Stages StageDescription GFR (ml/min/1.73 m 2 ) 1 Kidney damage with normal or ↑ GFR  90 2 Kidney damage with mild  GFR Kidney damage with moderate  GFR Severe  GFR Kidney Failure (ESRD) < 15 (or dialysis)

ESRD versus Total CKD

K/DOQI CKD Staging

Natural History of Nephropathy

Definition of ESRD vs Kidney Failure ESRD is a federal government defined term that indicates chronic treatment by dialysis or transplantation ESRD is a federal government defined term that indicates chronic treatment by dialysis or transplantation Kidney Failure: GFR < 15 ml/min/1.73 m 2 or on dialysis Kidney Failure: GFR < 15 ml/min/1.73 m 2 or on dialysis

Global profile of ESRD

Prevalence of Abnormalities at each level of GFR *>140/90 or antihypertensive medicationp-trend < for each abnormality

CKD Features – Stage wise CKDeGFRB.PACRUrineEdemaAnemia Ca x P SHPT Stage 1 >90NMAUNNoNoNNo Stage 2 60+↑MAU↑NoNNo Stage ↑ALB↑NoN Stage 4 15+↑ALB↑↓↑↑ Stage 5 <15↑↑ALB↓↑↑

Death rates from all causes (panel A) and cardiovascular events (panel B), as per eGFR Go, A, et al. NEJM 351: 1296

Physicians and Nephrologist in CKD

How to handle CKD ? A A1c < 6.5, ACEi, ARBs A A1c < 6.5, ACEi, ARBs BBlood pressure < 125/75 BBlood pressure < 125/75 CCholesterol LDL < 100 CCholesterol LDL < 100 DDrugs – avoid nephrotoxicity DDrugs – avoid nephrotoxicity Diet – Moderate in protein Na, K, Ph, Fluids, Cal Na, K, Ph, Fluids, Cal

CKD – Management Strategy 1. Decrease Cardiovascular Risk 2. Arrest or slow progression to ESRD 3. Manage complications – 1. Anemia (Normocytic normochromic) 2. Bone loss (Renal osteodystrophy)

CKD – Management Goals 1. Blood pressure < 125/75 HT is both a cause and consequence HT is both a cause and consequence 2. Glycemic control – Hb A1c < Hemoglobin level > 11 g% 4. Calcium x Phosphorous product < 50 Normal values : GFR 120 to 150 ml/min/1.73m2 Ca 9 to10.5mg%, Ph 3 to 4.5mg%, Ca x Ph < 50 iPTH 150 to 300 pg/ml

Early treatment makes a difference in CKD Brenner, et al., 2001

CKD death Stages in Progression of Chronic Kidney Disease and Therapeutic Strategies Complications Screening for CKD risk factors CKD risk reduction; Screening for CKD Diagnosis & treatment; Rx. comorbid conditions; ↓ progression Estimate progression; Rx. complications; Prepare for replacement Replacement by dialysis & transplant Normal Increased risk Kidney failure Damage  GFR

Stage-wise management of CKD Stage 0 Test for CKD, Management of Risk Factors Stage 1 Manage co-morbidity, Rx. of CVD and RF Stage 2 Slow rate of loss of Kidney function - ACEi Stage 3 Prevent Anemia, Bone effects, Ca x Ph Stage 4 Preparation for RRT; refer to nephrology Stage 5 RRT – PD, HD or RT – Donor / Cadavre

Preparation for RRT Choice of Renal Replacement Choice of Renal Replacement Timely Access Surgery Timely Access Surgery Timely Dialysis initiation Timely Dialysis initiation When GFR < 25ml/min When GFR < 25ml/min Renal transplant is the first choice Renal transplant is the first choice Workup living donors Workup living donors If no donors available If no donors available List patient on cadavre transplant list List patient on cadavre transplant list Place A-V fistula if HD preferred Place A-V fistula if HD preferred

Conclusions CKD – ESRD patient population is increasing in our country CKD – ESRD patient population is increasing in our country Early detection and proper management has many advantages Early detection and proper management has many advantages Later stages, i.e. ESRD – RRT is required Later stages, i.e. ESRD – RRT is required Various modalities of RRT – Dialysis (Hemo/ Peritoneal) as well as renal transplantation available Various modalities of RRT – Dialysis (Hemo/ Peritoneal) as well as renal transplantation available

Let this not happen please! Normal ESRD